Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katja Deterding

Showing results (41-50 of 98) with videos related to

Pageof 10
Sort By:
Journal of Hepatology|July 12, 2019
Elimination of hepatitis C virus has limited impact on the functional and mitochondrial impairment of HCV-specific CD8+ T cell responsesAmare Aregay, Solomon Owusu Sekyere, Katja Deterding, et al.
Journal of Hepatology|October 13, 2006
Hepatitis A virus infection suppresses hepatitis C virus replication and may lead to clearance of HCVKatja Deterding, Björn Tegtmeyer, Markus Cornberg, et al.
Journal of Viral Hepatitis|December 15, 2018
Role of soluble inflammatory mediators and different immune cell populations in early control of symptomatic acute hepatitis C virus infectionJulia Hengst, Andreas L Klein, Sebastian Lunemann, et al.
Zeitschrift Fur Gastroenterologie|November 30, 2017
Interferon-free cure of chronic Hepatitis C is associated with weight gain during long-term follow-upBernhard Schlevogt, Katja Deterding, Kerstin Port, et al.
European Journal of Gastroenterology & Hepatology|July 3, 2014
Limited effectiveness and safety profile of protease inhibitor-based triple therapy against chronic hepatitis C in a real-world cohort with a high proportion of advanced liver diseaseBenjamin Maasoumy, Kerstin Port, Katja Deterding, et al.
Hepatology Communications|September 25, 2021
HBcrAg Levels Are Associated With Virological Response to Treatment With Interferon in Patients With Hepatitis DeltaLisa Sandmann, Cihan Yurdaydin, Katja Deterding, et al.
Hepatology (Baltimore, Md.)|June 18, 2024
Letter to the Editor: The WHO HDV RNA international standard does not reflect variability of real-world samplesLisa Sandmann, Birgit Bremer, Katja Deterding, et al.
The Journal of Infectious Diseases|December 26, 2025
Transient interferon-driven NK cell activation in acute hepatitis CBenedikt Strunz, Qiuyao Zhan, Tanvi Khera, et al.
European Heart Journal Open|November 12, 2025
Secondary hyperparathyroidism in adult congenital heart disease: the CHD-HYPER-studyFriederike Löffler, Justus Christian Garlichs, Kirsten Linhorst, et al.
Antiviral Therapy|August 16, 2012
Evolution of adefovir-resistant HBV polymerase gene variants after switching to tenofovir disoproxil fumarate monotherapyFlorian van Bömmel, Jörg Trojan, Katja Deterding, et al.
Pageof 10

Showing results (41-50 of 98) with videos related to

Sort By:
Pageof 10
Journal of Hepatology|July 12, 2019
Elimination of hepatitis C virus has limited impact on the functional and mitochondrial impairment of HCV-specific CD8+ T cell responsesAmare Aregay, Solomon Owusu Sekyere, Katja Deterding, et al.
Journal of Hepatology|October 13, 2006
Hepatitis A virus infection suppresses hepatitis C virus replication and may lead to clearance of HCVKatja Deterding, Björn Tegtmeyer, Markus Cornberg, et al.
Journal of Viral Hepatitis|December 15, 2018
Role of soluble inflammatory mediators and different immune cell populations in early control of symptomatic acute hepatitis C virus infectionJulia Hengst, Andreas L Klein, Sebastian Lunemann, et al.
Zeitschrift Fur Gastroenterologie|November 30, 2017
Interferon-free cure of chronic Hepatitis C is associated with weight gain during long-term follow-upBernhard Schlevogt, Katja Deterding, Kerstin Port, et al.
European Journal of Gastroenterology & Hepatology|July 3, 2014
Limited effectiveness and safety profile of protease inhibitor-based triple therapy against chronic hepatitis C in a real-world cohort with a high proportion of advanced liver diseaseBenjamin Maasoumy, Kerstin Port, Katja Deterding, et al.
Hepatology Communications|September 25, 2021
HBcrAg Levels Are Associated With Virological Response to Treatment With Interferon in Patients With Hepatitis DeltaLisa Sandmann, Cihan Yurdaydin, Katja Deterding, et al.
Hepatology (Baltimore, Md.)|June 18, 2024
Letter to the Editor: The WHO HDV RNA international standard does not reflect variability of real-world samplesLisa Sandmann, Birgit Bremer, Katja Deterding, et al.
The Journal of Infectious Diseases|December 26, 2025
Transient interferon-driven NK cell activation in acute hepatitis CBenedikt Strunz, Qiuyao Zhan, Tanvi Khera, et al.
European Heart Journal Open|November 12, 2025
Secondary hyperparathyroidism in adult congenital heart disease: the CHD-HYPER-studyFriederike Löffler, Justus Christian Garlichs, Kirsten Linhorst, et al.
Antiviral Therapy|August 16, 2012
Evolution of adefovir-resistant HBV polymerase gene variants after switching to tenofovir disoproxil fumarate monotherapyFlorian van Bömmel, Jörg Trojan, Katja Deterding, et al.
Pageof 10